Rumik Agnieszka, Paradowska-Stankiewicz Iwona
Zakład Epidemiologii Chorób Zakaźnych i Nadzoru, Narodowy Instytut Zdrowia Publicznego PZH - Państwowy Instytut Badawczy.
Przegl Epidemiol. 2024 Dec 31;78(4):428-438. doi: 10.32394/pe/195724. Epub 2024 Nov 19.
The epidemiological situation of pertussis in Poland in 2022 was influenced by the cancellation of the COVID-19 epidemic and the introduction of an epidemic threat. Decisions related to the gradual easing of restrictions on social contacts and the abolition of the obligation to wear masks caused the number of pertussis cases to slowly start to increase. The most effective strategy for preventing pertussis remains the immunization of children in accordance with the National Immunization Program, and in the case of adults, vaccination repeated systematically every 10 years and immunization of pregnant women in the second/third trimester of each pregnancy. Pertussis remains a public health problem because the immunity obtained through vaccination does not last a lifetime.
The aim of the study was to assess the epidemiological situation of pertussis in Poland in 2022 compared to the situation in previous years, with particular emphasis on assessing the impact of the COVID-19 pandemic and assessing the vaccination status of children against pertussis.
The assessment of the epidemiological situation of pertussis in Poland was made based on the results of the analysis of individual reports on pertussis cases registered at the NIPH NIH - NRI in the Epibaza system and data from the annual bulletins "Infectious diseases and poisonings in Poland" and the bulletin "Vaccinations in Poland in 2022".
In 2022, 371 cases of pertussis were recorded. The incidence was 0.98/100 000 and was 104% higher than in 2021. The highest incidence of pertussis occurred in children aged 0-4 years (6.7/100 000), and high in children aged 5-9 years (2.0/100 000). Over 51% of cases concerned people over 15 years of age. A higher incidence was observed in women in general compared to men, and a higher incidence in cities than in rural areas. In 2022, among people with pertussis, 151 (41%) required hospitalization. In 2022, the vaccination rate of children aged 2 years with 4 doses of the pertussis vaccine was 94.3% in total. In 2022, one case of disease resulting in death due to pertussis was reported to the epidemiological surveillance system.
In Poland, in 2022, there was an increase in the number of pertussis cases compared to the previous year, which was undoubtedly influenced by the gradual lifting of restrictions on social contacts and the obligation to wear masks. The increase in the number of people susceptible to pertussis may lead to the occurrence of compensatory epidemics in the future, therefore a high level of vaccination of the population (above 95%) should be maintained to prevent new cases.
2022年波兰百日咳的流行病学情况受到新冠疫情解除及引入疫情威胁的影响。与逐步放宽社交接触限制和取消戴口罩义务相关的决定导致百日咳病例数开始缓慢增加。预防百日咳最有效的策略仍然是按照国家免疫规划对儿童进行免疫接种,对于成年人,每10年系统重复接种疫苗以及在每次怀孕的第二/三个月对孕妇进行免疫接种。百日咳仍然是一个公共卫生问题,因为通过疫苗接种获得的免疫力不会持续一生。
本研究的目的是评估2022年波兰百日咳的流行病学情况,并与前几年的情况进行比较,特别强调评估新冠疫情的影响以及评估儿童百日咳疫苗接种状况。
基于对在Epibaza系统中波兰国家公共卫生研究所 - 国家感染研究所登记的百日咳病例个体报告的分析结果以及年度公报《波兰的传染病和中毒》和公报《2022年波兰的疫苗接种》中的数据,对波兰百日咳的流行病学情况进行评估。
2022年记录了371例百日咳病例。发病率为0.98/10万,比2021年高104%。百日咳发病率最高的是0至4岁儿童(6.7/10万),5至9岁儿童发病率也较高(2.0/10万)。超过51%的病例涉及15岁以上人群。总体而言,女性的发病率高于男性,城市的发病率高于农村地区。2022年,在百日咳患者中,151人(41%)需要住院治疗。2022年,2岁儿童4剂百日咳疫苗的总体接种率为94.3%。2022年,有1例因百日咳导致死亡的病例报告给了流行病学监测系统。
在波兰,2022年百日咳病例数比上一年有所增加,这无疑受到社交接触限制和戴口罩义务逐步解除的影响。易患百日咳人数的增加可能导致未来出现代偿性流行,因此应保持高水平的人群疫苗接种率(95%以上)以预防新病例。